Sai Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 4, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	184,089	158,581	-	-	-	-
Enterprise Value	185,203	166,413	-	-	-	-
Last Close Price	875.90	760.85	-	-	-	-
PE Ratio	64.22	93.21	-	-	-	-
Forward PE	52.83	72.51	-	-	-	-
PS Ratio	8.97	9.36	-	-	-	-
PB Ratio	8.11	7.45	-	-	-	-
P/TBV Ratio	8.14	7.49	-	-	-	-
P/OCF Ratio	60.25	50.50	-	-	-	-
EV/Sales Ratio	9.02	9.82	-	-	-	-
EV/EBITDA Ratio	34.42	46.28	-	-	-	-
EV/EBIT Ratio	46.47	61.49	-	-	-	-
Debt / Equity Ratio	0.18	0.17	0.95	1.05	1.10	0.78
Debt / EBITDA Ratio	0.78	0.88	3.28	5.80	8.18	4.12
Debt / FCF Ratio	-	-	11.40	8.77	-	-
Asset Turnover	0.71	0.62	0.66	0.56	0.44	-
Inventory Turnover	5.41	4.97	4.27	3.50	3.04	-
Quick Ratio	1.03	1.58	1.05	0.93	0.99	1.05
Current Ratio	1.92	2.05	1.28	1.27	1.32	1.34
Return on Equity (ROE)	17.28%	10.96%	8.89%	1.13%	0.71%	-
Return on Assets (ROA)	8.58%	6.22%	4.83%	1.90%	0.98%	-
Return on Capital (ROIC)	10.54%	7.72%	5.78%	2.25%	1.15%	-
Return on Capital Employed (ROCE)	15.60%	11.10%	11.20%	4.60%	2.10%	7.10%
Earnings Yield	1.56%	1.07%	-	-	-	-
FCF Yield	-1.07%	-0.35%	-	-	-	-
Buyback Yield / Dilution	-13.02%	-8.04%	-0.27%	-0.46%	-5.32%	-

Source: S&P Capital IQ. Standard template. Financial Sources.